Press Enter / Return to begin your search.

23andMe CEO: I’ll Sleep When We Bring Our Full Test Back To Market

Anne Wojcicki is committed to resuming the personal genomics company’s test for pharmacogenetics and disease risks.

Anne Wojcicki is the first to admit that she has tunnel vision. The battle-weary CEO of 23andMe knows exactly where her company needs to be in the next five years.

Read Full Story

Leave a Reply